Michael Hayden has served as our Chief Scientific Officer since March 1999 and has been a member of Xenon's Board of Directors since November 1996. He is currently a full professor of Medical Genetics at the University of British Columbia, as well as Director of the Center for Molecular Medicine and Therapeutics (CMMT) in Vancouver; the CMMT is a gene research center under UBC's Faculty of Medicine. Author of over 400 peer-reviewed publications and invited submissions, Dr. Hayden focuses his research primarily on genetic diseases, including genetics of lipoprotein disorders, Huntington's disease and predictive medicine. In association with his colleagues, Dr. Hayden developed the proposal which led to the award of the Canadian Centers of Excellence on the genetic basis of disease. This effort has been furthered by his involvement in the Canadian Genetic Diseases Network; Dr. Hayden has served as the Network's Scientific Director since its inception in 1990.
The recipient of numerous prestigious honors and awards, Dr. Hayden was elected to the American Society of Clinical Investigation in 1992, to the Board of the American Society of Human Genetics in 1994 and to the Royal Society of Canada in 1995. Among his most recent awards are the 1998 Distinguished Scientist Award of the Canadian Society of Clinical Investigation, the 2000 BC Biotechnology Alliance Award for Vision and Leadership and in 2001, Dr. Hayden received both the award of Excellence of the Genetics Society of Canada and the Ottawa Life Sciences Award of Merit. |
